Apos®’ Efficacy Validated in UK Study According to Pain Reduction, Functional Improvement, Quality of Life, and Velocity Measurements

A study of 455 patients with knee osteoarthritis demonstrated that Apos® improves gait pattern, pain, function, and quality of life within 3 to 6 months.

UK patients suffering from symptomatic knee osteoarthritis were treated with a biomechanical, foot worn device (Apos®) that was individually calibrated to alleviate knee pain and promote neuromuscular training. Following 3 months of treatment, patients walked faster, taking longer steps, and showing better ability to support their body weight on a single limb. In addition, participants in the study reported having less pain and functional limitation and better quality of life. All clinical outcomes further improved after 6 months of treatment.

Link: https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-020-03382-3

Miles C, Greene A. The effect of treatment with a non-invasive foot worn biomechanical device on subjective and objective measures in patients with knee osteoarthritis- A retrospective analysis on a UK population. BMC Musculoskeletal Disorders. 2020; 21:386.

See if you qualify for Apos®.

Many insurances cover Apos® completely!

In case your healthcare coverage is not listed, please choose "Other."

Before you go…

Don’t miss out on this must-read e-book
Your knees and back will thank you!.

Check out our e-book of Myths & Facts About Knee & Back Pain.

Enter your email to start reading